Edotreotide is a cyclic peptide conjugate of octreotide and DOTA, designed as a pharmaceutical raw material for use in radiolabeling studies. Its complex structure features multiple amide bonds, a disulfide bridge, and a DOTA chelator capable of coordinating various radioisotopes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Edotreotide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
DOTA-TATE acetate
pharmaceutical raw material
DOTA-NOC
research compound
Acetyl-Octreotide
pharmaceutical raw material
Melittin
pharmaceutical raw material
Liraglutide
pharmaceutical raw material
Valerianol
pharmaceutical raw material
(R,R)-Epoxy Leucine Carfilzomib
pharmaceutical raw material
The international HS code for Edotreotide (CAS 204318-14-9) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
RZHKDBRREKOZEW-AAXZNHDCSA-N
C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@H](CO)[C@@H](C)O)O
Sourcing Edotreotide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.